CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Maryland

KFAR SABA, Israel, Oct. 15, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the first implantation of the Agili-C™ implant, as part of Investigational Device Exemption (IDE) clinical study by Dr. Jason M. Scopp, orthopedic surgeon and Director of Joint Preservation Center at Peninsula Orthopaedic Clinic in Salisbury, Maryland.
The clinical study will involve a minimum of 250 study patients, currently 241 patients have already been enrolled.
You can read more
Tags: